State Street

State Street is a global financial services company specializing in investment servicing and management for institutional investors, with $41.8 trillion in assets under custody and $4.1 trillion in assets under management as of December 2023. Its asset management subsidiary, State Street Global Advisors (SSGA), is primarily an index manager, with 85% of its assets invested in index strategies for clients[1]. The company provides services such as accounting, administration, daily pricing, investment management, securities lending, foreign exchange, trading, and information services[5]. State Street does not directly engage in biotech, pharma, or healthcare drug development, but its financial products (such as ETFs) provide exposure to the biotech sector for investors[8][9].